| Literature DB >> 30200411 |
Tiziana Marino1, Francesca Russo2, Alberto Figoli3.
Abstract
The present investigation reports as it is possible to prepared polyvinylidene fluoride (PVDF) membranes for microfiltration (MF) and ultrafiltration (UF) applications, by using triethyl phosphate (TEP) as non⁻toxic solvent in accordance with the Green Chemistry. Casting solutions containing different concentrations of polyethylene glycol (PEG) were prepared in order to study its effect on the final membrane morphology and properties. The possibility to finely modulate membrane properties was also investigated by applying two different membrane preparation techniques, the Non-Solvent Induced Phase Separation (NIPS) and its coupling with Vapour Induced Phase Separation (VIPS). Membranes' morphology was detected by Scanning Electron Microscopy (SEM). Thickness, porosity, contact angle, pore size and water permeability were also recorded. Both the PEG content in the dope solution and the selected time intervals during which the nascent films were exposed to established relative humidity and temperature were found to play a crucial role in membrane formation. In particular, it was demonstrated as, by varying PEG content between 10 and 20 wt %, and by setting the exposure time to humidity at 0/2.5/5/7.5 min, membranes with different pore diameter and bicontinuous structure, suitable for UF and MF applications, could be easily obtained.Entities:
Keywords: PVDF membranes; VIPS-NIPS; membrane preparation, TEP; non-toxic triethyl phosphate
Year: 2018 PMID: 30200411 PMCID: PMC6160958 DOI: 10.3390/membranes8030071
Source DB: PubMed Journal: Membranes (Basel) ISSN: 2077-0375
Hazard statements for DMF, DMA and NMP according to Regulation (EC) No 1272/2008 [3,4].
| Solvent | Hazard Statements | |
|---|---|---|
| DMF |
| |
| GERM CELL MUTAGENICITY:MOUSE, LYMPHOCYTE. MUTATION IN MAMMALIAN SOMATIC CELLS. | ||
| DMA |
| |
| MAY CAUSE CONGENITAL MALFORMATION IN THE FETUS. PRESUMED HUMAN REPRODUCTIVE TOXICANT OVEREXPOSURE MAY CAUSE REPRODUCTIVE DISORDER(S) BASED ON TESTS WITH LABORATORY ANIMALS. | ||
| NMP |
| |
| DAMAGE TO FETUS POSSIBLE. | ||
| TEP |
| |
| THIS SUBSTANCE/MIXTURE CONTAINS NO COMPONENTS CONSIDERED TO BE EITHER PERSISTENT, BIOACCUMULATIVE AND TOXIC, OR VERY PERSISTENT AND VERY BIOACCUMULATIVE AT LEVELS OF 0.1% OR HIGHER. | ||
Figure 1Molecular structure of TEP.
Hansen solubility parameters and polymer–solvent distance.
| Compound | Hydrogen Bond Force | Dispersion Force | Polar Force | Solubility Parameter | Polymer–Solvent (S) Affinity | Solvent–Non-Solvent (NS) Affinity | Reference |
|---|---|---|---|---|---|---|---|
| δh | δd | δp | δsp | δPVDF−S | δS−NS | δh | |
| PVDF | 9.2 | 17.2 | 12.5 | - | - | - | [ |
| TEP | 9.2 | 16.8 | 11.5 | 22.2 | 1.1 | 33.4 | [ |
| DMF | 11.3 | 17.4 | 13.7 | 24.8 | 2.4 | 31.1 | [ |
| DMA | 11.8 | 17.8 | 14.1 | 22.7 | 1.4 | 32.4 | [ |
| NMP | 7.2 | 18.4 | 12.3 | 22.9 | 2.2 | 35.4 | [ |
| WATER | 42.3 | 15.6 | 16.0 | 47.8 | - | - | [ |
PVDF membranes produced by varying casting solution composition and exposure time to fixed humidity and temperature.
| Membrane Code | PVDF/wt % | PVP/wt % | PEG/wt % | TEP/wt % | Exposure Time to Rh/min |
|---|---|---|---|---|---|
| M1 | 15 | 5 | 10 | 70 | 0 |
| M2 | 15 | 5 | 10 | 70 | 2.5 |
| M3 | 15 | 5 | 10 | 70 | 5 |
| M4 | 15 | 5 | 10 | 70 | 7.5 |
| M5 | 15 | 5 | 15 | 65 | 0 |
| M6 | 15 | 5 | 15 | 65 | 2.5 |
| M7 | 15 | 5 | 15 | 65 | 5 |
| M8 | 15 | 5 | 15 | 65 | 7.5 |
| M9 | 15 | 5 | 20 | 60 | 0 |
| M10 | 15 | 5 | 20 | 60 | 2.5 |
| M11 | 15 | 5 | 20 | 60 | 5 |
| M12 | 15 | 5 | 20 | 60 | 7.5 |
Figure 2(a) Casting solution composition 15 wt % PVDF, 5 wt % PVP, 10 wt % PEG, 70 wt % TEP; (b) Casting solution composition 15 wt % PVDF, 5 wt % PVP, 15 wt % PEG, 65 wt % TEP; (c) Casting solution composition 15 wt % PVDF, 5 wt % PVP, 20 wt % PEG, 60 wt % TEP.
Thickness, porosity and contact angle of the PVDF membranes prepared by NIPS and NIPS-VIPS.
| Membrane Code | Thickness (mm) | Porosity (%) | Contact Angle | |
|---|---|---|---|---|
| Air Side (°) | Glass Side (°) | |||
| M1 | 0.160 ± 0.002 | 83.3 ± 0.4 | 77 ± 2 | 98 ± 2 |
| M2 | 0.150 ± 0.001 | 80.6 ± 0.5 | 83 ± 1 | 99 ± 2 |
| M3 | 0.154 ± 0.001 | 81.8 ± 0.6 | 87 ± 2 | 99 ± 1 |
| M4 | 0.158 ± 0.001 | 82.4 ± 0.4 | 88 ± 2 | 100 ± 2 |
| M5 | 0.164 ± 0.004 | 85.5 ± 0.4 | 78 ± 2 | 99 ± 2 |
| M6 | 0.152 ± 0.001 | 82.8 ± 0.5 | 87 ± 2 | 100 ± 1 |
| M7 | 0.156 ± 0.003 | 84.5 ± 0.4 | 92 ± 2 | 101 ± 2 |
| M8 | 0.159 ± 0.001 | 84.9 ± 0.6 | 94 ± 3 | 104 ± 1 |
| M9 | 0.164 ± 0.002 | 86.5 ± 0.4 | 84 ± 2 | 99 ± 1 |
| M10 | 0.158 ± 0.001 | 85.6 ± 0.6 | 98 ± 2 | 101 ± 2 |
| M11 | 0.160 ± 0.002 | 86.4 ± 0.5 | 101 ± 1 | 103 ± 2 |
| M12 | 0.162 ± 0.002 | 86.6 ± 0.4 | 102 ± 2 | 106 ± 1 |
Figure 3Mean flow pore diameter of the prepared membranes (in all cases, the relative standard error was less than 5%).
Figure 4PWP of the membranes prepared via: (A) NIPS; (B) VIPS-NIPS (in all cases, the relative standard error was less than 5%).
Comparison between the most relevant results obtained in this work and those reported in literature related to PVDF membrane preparation via NIPS-VIPS.
| Solvent Type | RH% | Exposure Time to Humid Air | Mean Pore Diameter | PWP | Potential Applications | Ref. |
|---|---|---|---|---|---|---|
| Min | mm | L/m2·h·BAR | ||||
| DMA | 100 | 0 | 0.11 | - | Vacuum membrane distillation (VMD) | [ |
| 3 | 0.11 | |||||
| 5 | 0.11 | |||||
| 6 | 0.11 | |||||
| DMA | 60 | 2 | 0.06 | - | Direct contact membrane distillation (DCMD) | [ |
| 5 | 0.06 | |||||
| 10 | 0.14 | |||||
| 80 | 2 | 0.07 | ||||
| 5 | 0.13 | |||||
| 10 | 0.14 | |||||
| DMA | 100 | 0 | 0.34 | - | VMD | [ |
| 1 | 0.62 | |||||
| 2 | 0.8 | |||||
| 5 | 1.02 | |||||
| DMF | 30 ± 5 | 0.5 | - | 99.6 | MF | [ |
| DMA | 87.7 | |||||
| TEP | 89.1 | |||||
| DMSO | 272.1 | |||||
| TEP | 55 | 0 | 0.14 | 290 | UF–MF | This work |
| 2.5 | 0.43 | 7900 | ||||
| 5 | 0.42 | 2300 | ||||
| 7.5 | 0.45 | 7800 |